TY - JOUR
T1 - Insights on Multiple Myeloma Treatment Strategies
AU - Mateos, María-Victoria
AU - Ludwig, Heinz
AU - Bazarbachi, Ali
AU - Beksac, Meral
AU - Bladé, Joan
AU - Boccadoro, Mario
AU - Cavo, Michele
AU - Delforge, Michel
AU - Dimopoulos, Meletios A
AU - Facon, Thierry
AU - Geraldes, Catarina
AU - Goldschmidt, Hartmut
AU - Hájek, Roman
AU - Hansson, Markus
AU - Jamroziak, Krzysztof
AU - Leiba, Merav
AU - Masszi, Tamás
AU - Mendeleeva, Larisa
AU - O'Dwyer, Michael
AU - Plesner, Torben
AU - San-Miguel, Jesús F
AU - Straka, Christian
AU - van de Donk, Niels W C J
AU - Yong, Kwee
AU - Zver, Samo
AU - Moreau, Philippe
AU - Sonneveld, Pieter
N1 - Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
PY - 2019/2
Y1 - 2019/2
N2 - The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.
AB - The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.
U2 - 10.1097/HS9.0000000000000163
DO - 10.1097/HS9.0000000000000163
M3 - Journal article
C2 - 31723802
SN - 2572-9241
VL - 3
JO - HemaSphere
JF - HemaSphere
IS - 1
M1 - e163
ER -